Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Human papillomavirus family
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Human papillomavirus family
Human papillomavirus (HPV) a non-enveloped virus accounted as the most important causative agent of cervical cancer worldwide with more than 45,000 diagnosed cases annually (1). Even after establishment of encouraging vaccine platforms for it,s prevention due to shortages of this supplements the infection rate remained accelerating in developing country. Yet, more than 100 types of HPV distinguished by genetic analysis among them types 16 and 18 belonged to definite carcinogens group are responsible for more than 62% and 15% of cervical cancers respectively(2, 3). The major limitation associated with current HPV available vaccines is their useless application for therapeutic approaches indeed so developing a suitable therapeutic vaccine remained a big challenge in this era (4) . In persistent infection like HPV related diseases, therapeutic vaccine open a new horizon for better control of disease by improving the cellular immune arm against virus proteins expressed in host cells (5). Among different therapeutic vaccine strategies including virus based vectors, peptide vaccine, whole bacterial vectors, recombinant DNA vaccine, protein based vaccine has its special situation in HPV related diseases therapy. Protein-based vaccines are capable of generating CD8+ T-cell responses either on humoral immune response in vaccinated animals (6). Also while this kind of vaccines is safer compared to bacterial/viral and circumvent MHC restriction in spite of peptide vaccines however has some shortages most importantly poor immunogenicity when compared to others (2). Thus, novel HPV protein-based vaccines require new strategies for promotion of consequent CD8+ and humoral related immune responses to combat disease progression. Up to now sever... ... middle of paper ... ...g Y, Hewitt D, Jacobs A, et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine. 2008 Jan 10;26(2):201-14. PubMed PMID: 18063235. Epub 2007/12/08. eng. 27. Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, et al. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine. 2010 Dec 6;28(52):8268-74. PubMed PMID: 20969925. Epub 2010/10/26. eng. 28. Wang BZ, Quan FS, Kang SM, Bozja J, Skountzou I, Compans RW. Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. Journal of virology. 2008 Dec;82(23):11813-23. PubMed PMID: 18786995. Pubmed Central PMCID: PMC2583664. Epub 2008/09/13. eng.
However due to globalization, import and export viruses is more easily transmitted. Over the past century the global community especially Asian has been affected with new strains of the influenza virus. The changes in the virus can occur in two ways “antigenic drift” which are gradual changes in the virus over time. This change produces new strains that the antibody may not recognize. “Antigenic shift” On the other is a sudden change in the influenza virus which ‘’ results in a new influenza A subtype or a virus with a hemagglutinin or a hemagglutinin and neuraminidase combination that has emerged from an animal population,” as seen with H5N1 virus. This change leaves people defenseless against this new virus. (CDC, 2013) Currently there is no vaccine to combat all strains therefore “Planning and preparedness for implementing mitigation strategies during a pandemic requires participation by all levels o...
The article’s information is presented with the goal of informing a reader on vaccines. The evidence is statistical and unbiased, showing data on both side effects and disease prevention, providing rates of death and serious illness from both sides. This evidence is sourced from a variety of medical organizations and seems reliable, logical, and easily understood, no language that would inspire an emotional response is used. The validity of studies is not mentioned in the article, but it does encourage readers to investigate further to help make a decision. The article allows a reader to analyze the presented evidence and come to their own
Current influenza vaccines are about 70% to 90% effective in preventing influenza in healthy adults. Since the vaccines are made of dead fragments of influenza viruses, they cannot cause influenza. The strains of influenza that circulate change every year and therefore, it is necessary to make a new influenza vaccine annually. After vaccination, the body's immune system produces antib... ... middle of paper ... ...
Loo, Yueh-Ming and Michael Gale, Jr. “Influenza: Fatal Immunity and the 1918 Virus.” Nature 445 (2007): 267-268. 23 July. 2008 .
Omer, S. B., Salmon, D.A., Orenstein, W. A., deHart, M. P., & Halsey, N. (2009). Vaccine
Kimball, Dr. John. A.S.A. “Influenza.” 8 Feb. 2007. Kimball’s Biology Page. 23 July 2007 http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/I/Influenza.html>.
Influenza is a major public health problem which outbreaks all over the world. Resulting in considerable sickness and death rates. Furthermore, it is a highly infectious airborne disease and is caused by the influenza virus. Influenza is transmitted easily from one person to another person which has a great impact on society. When a member of society becomes sick, it is more prone to spread to other people. In the United States, every year between 5 to 20 percent of the population is affected by influenza. As a result of this, between 3,000 and 49,000 deaths have occurred per year (Biggerstaff et al., 2014). Therefore, the influenza vaccine is the most effective strategy to prevent influenza. This essay will examine two significant reasons for influenza vaccination which are the loss of workforce and economic burden as well as one effect regarding herd immunity.
Influenza is very contagious and spreads rapidly from person to person. Influenza causes worldwide yearly epidemics. According to World Health organization Influenza affects 5-15% world’s population and resulting in 500,000 deaths yearly. Ottenberg stated that, in United States, an average of 200,000 were hospitalized and 36,000 died each year from influenza complications. Influenza is the sixth leading cause of death among US adults and is related to 1 in 20 death in persons older than 65 years. Disease control and prevention estimates indicate that infections like H1N1 which is one of the types of influenza, have resulted in an estimated 42 to 86 million cases and 8520 to 17620 deaths. As I mentioned earlier that infections like influenza are very contagious, they can spread easily from hcw to Patient and back to hcw. The most efficient and effective method of preventing influenza infection is vaccination(The best way to prevent influenza is with annual vaccination).(Sullivan,2010) (Gregory,Tosh &Jacobson, 2005). Motivated by a desire to actively avoid illness Influenza may increase the risk for death in people with existing heart, lung, or circulation disorders. In fact, the higher than average number of winter deaths in people with heart disease may be due only to the occurrence of influenza during those months.Vaccination provides immunity to fight against infection.To increase resistance to harm by modifying the environment to minimize preventable illness (NEED TO CHANGE WORDING)
Ng, Sophia, et al. "The Effect Of Age And Recent Influenza Vaccination History On The Immunogenicity And Efficacy Of 2009-10 Seasonal Trivalent Inactivated Influenza Vaccination In Children." Plos One 8.3 (2013): e59077. MEDLINE. Web. 15 Nov. 2013.
“Selecting the Viruses in the Seasonal Influenza (Flu) Vaccine.” Centers for Disease Control and Prevention. USA.gov, 9 March 2011. Web. 19 Jan. 2010
Ovarian Cancer is a disease of uncontrollably dividing cancer cells in the ovary. Being one of the most devastating diseases to have, along with a limited number of treatment opportunities, it may feel like there has been a time stamp put on your life. With that said, there are four different types of ovarian cancer: epithelial tumors, germ cell carcinoma tumors, stromal carcinoma tumors, and small cell carcinoma of the ovary. Epithelium cancer is the fourth leading cause of death in women in the United States, killing approximately 140,000 women yearly.
In order to decide whether or not the swine flu vaccine is completely necessary, one must first gain a better understanding of the topic. It is a scientifically known fact that the swine flu is a result of a virus. A virus is a capsule of genetic material that causes infection in the body. The infectious particles are made up of nucleic acid enclosed in a protein shell, called a capsid. It cannot be considered a living organism like the disease causing agent of bacteria, because it does not carry out all the characteristics of life. Specifically, it cannot reproduce on its own.
To decrease the number of cervical cancer women need to aware about the HPV vaccine and
...gens are exogenous (outside the cell) and will be presented to helper T cells to initiate an immune response. This can trigger cytotoxic T cells to kill cancer cells with the same antigen – often HPV viral proteins in cervical cancer. T cells may not be activated to their full potential – recall that the inhibitory receptor CTLA-4 on T cells sends a stronger signal than CD28, the activating receptor. Ipilimumab is added to treatment for this reason. It will work in conjunction with the released antigens, activating the T cells that can respond to the antigens and create an immune response against the cancer cells (LACC article). Adding ipilimumab to the chemo/radiation treatment would enhance the immune system’s ability to respond to the antigen released by the treatment. This is the first time a treatment like this has been suggested for cervical cancer (LACC).
It is purified from Salmonella minnesota lipopolysaccharide (LPS) and is being used for preventing human papillomavirus (HPV) and hepatitis B virus (HBV) infections. A combination adjuvant of MPLA with alum (AS04) used for HPV vaccination has been shown to be effective compared to administration of only alum along with antigen.16 The AS04 was shown to enhance humoral and B-cell immunity as well as produced antibody titers faster than alum.17 A number of studies consisting use of TLR adjuvants either alone or in combination with other immunoadjuvant are underway to explore the potential of TLR adjuvants for human use. For example, the addition of GPG 7909, a TLR9, to a commercial HBV vaccine enhanced the kinetics, magnitude, and longevity of the seroprotective response over 5 year period.18 In another mice immunization study, it has been shown that administration of nanoparticles containing combination of TLR4 and TLR7 ligands along with antigen synergistically increased antigen-specific, neutralizing antibodies compared to nanoparticles consisting only one TLR immunoadjuvant.19 TLR2 recognizes bacterial lipoproteins such as thioether linked diacyl-glycerol attached to the N-terminal cysteine of secreted proteins that may also carry N-linked acyl chains.20 TLR2 is expressed on multiple cells such as lymphocytes, macrophages, and dendritic cells. The lipopeptide ligands such as Pam3CysSK4 that activate these receptors stimulate a wider array of adjuvant functions.14 Studies have demonstrated that Pam3CysSK4 has multiple roles that include DC maturation, activation of macrophages to release cytokines, promoting maturation and stimulation of B cells that produce antigen-specific antibodies and boosting the production of